13F

Stock

Acrivon Therapeutics, Inc.

ACRV · held by 2 managers

Reported value

$325.5K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$42.3K

Price effect on 2 books still in the name

Largest holder

$233.1K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC33.3K$233.1K$26.4KAdded$105.3K
Marex Group plc13.2K$92.3K$15.8KAdded$15.8K

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.